Clinical Trial Details
| Trial ID: | L0730 |
| Source ID: | NCT06520826 |
| Associated Drug: | Vadadustat |
| Title: | Vafseo Outcomes In-Center Experience |
| Acronym: | VOICE |
| Status: | RECRUITING |
| Study Results: | NO |
| Results: | |
| Conditions: | Anemia of Chronic Kidney Disease |
| Interventions: | DRUG: Vadadustat|DRUG: Erythropoiesis Stimulating Agent |
| Outcome Measures: | Primary: All-cause mortality, 18 months | Secondary: All-cause hospitalization, 18 months |
| Sponsor/Collaborators: | Sponsor: USRC Kidney Research | Collaborators: Akebia Therapeutics |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | PHASE3 |
| Enrollment: | 2200 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT |
| Start Date: | 2024-11-20 |
| Completion Date: | 2026-06-30 |
| Results First Posted: | |
| Last Update Posted: | 2024-12-11 |
| Locations: | USRC Kidney Research, Lone Tree, Colorado, 80124, United States|Nephrology and Hypertension Specialists, PC, Dalton, Georgia, 30720, United States|US Renal Care - Gallup, Gallup, New Mexico, 87301, United States|Dallas Renal Group, Dallas, Texas, 75230, United States|US Renal Care - Live Oak, Live Oak, Texas, 78233, United States |
| URL: | https://clinicaltrials.gov/show/NCT06520826 |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|